Kenneth Byrd, DO | |
3901 Rainbow Blvd, Kansas City, KS 66160 | |
(913) 588-5000 | |
Not Available |
Full Name | Kenneth Byrd |
---|---|
Gender | Male |
Speciality | Hematology |
Experience | 12 Years |
Location | 3901 Rainbow Blvd, Kansas City, Kansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1598026338 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | 0541001 (Kansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Kansas Hospital | Kansas city, KS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Of Kansas Hospital Authority | 9436054798 | 250 |
News Archive
Researchers from Bochum have detected an olfactory receptor in the human bladder that might prove useful for bladder cancer therapy and diagnosis.
One-third of lesbian, gay, bisexual and transgender youth have attempted suicide in their lifetime - a prevalence comparable to urban, minority youth - but a majority do not experience mental illness, according to a report by researchers at the University of Illinois at Chicago.
President Obama's sweeping proposals to combat gun violence represent a sound response to the mass shootings that have horrified the country. In his legislative proposals and executive actions announced Wednesday, the president and Vice President Biden showed a willingness to confront a difficult problem head-on - a problem that is not only about laws but also about culture and mental-health care.
MAP Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2012.
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.
› Verified 9 days ago
Entity Name | University Of Kansas Hospital Authority |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1528019502 PECOS PAC ID: 9436054798 Enrollment ID: O20050908001103 |
News Archive
Researchers from Bochum have detected an olfactory receptor in the human bladder that might prove useful for bladder cancer therapy and diagnosis.
One-third of lesbian, gay, bisexual and transgender youth have attempted suicide in their lifetime - a prevalence comparable to urban, minority youth - but a majority do not experience mental illness, according to a report by researchers at the University of Illinois at Chicago.
President Obama's sweeping proposals to combat gun violence represent a sound response to the mass shootings that have horrified the country. In his legislative proposals and executive actions announced Wednesday, the president and Vice President Biden showed a willingness to confront a difficult problem head-on - a problem that is not only about laws but also about culture and mental-health care.
MAP Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2012.
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Kenneth Byrd, DO 2330 Shawnee Mission Pkwy, Westwood, KS 66205-2005 Ph: (913) 588-6078 | Kenneth Byrd, DO 3901 Rainbow Blvd, Kansas City, KS 66160 Ph: (913) 588-5000 |
News Archive
Researchers from Bochum have detected an olfactory receptor in the human bladder that might prove useful for bladder cancer therapy and diagnosis.
One-third of lesbian, gay, bisexual and transgender youth have attempted suicide in their lifetime - a prevalence comparable to urban, minority youth - but a majority do not experience mental illness, according to a report by researchers at the University of Illinois at Chicago.
President Obama's sweeping proposals to combat gun violence represent a sound response to the mass shootings that have horrified the country. In his legislative proposals and executive actions announced Wednesday, the president and Vice President Biden showed a willingness to confront a difficult problem head-on - a problem that is not only about laws but also about culture and mental-health care.
MAP Pharmaceuticals, Inc. today announced financial results for the first quarter ended March 31, 2012.
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.
› Verified 9 days ago
Micholee Beth Polsak, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, 6040 Delp, Ms 1020, Kansas University Physicians Inc, Kansas City, KS 66160 Phone: 913-588-3974 Fax: 913-588-6055 | |
Ira William Marsh, MD Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 8929 Parallel Pkwy, Kansas City, KS 66112 Phone: 913-596-4000 | |
Dr. Tara L Lin, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6030 Fax: 913-588-4085 | |
Kristin N Fee, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd # Ms 2027, Kansas City, KS 66160 Phone: 913-588-3974 Fax: 913-588-6055 | |
Donald J. Mcsweyn, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8919 Parallel Pkwy, Suite 580, Kansas City, KS 66112 Phone: 913-596-7224 Fax: 913-596-7257 | |
Dr. Dhanunjaya Lakkireddy, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Suite#g600, Kansas City, KS 66160 Phone: 913-588-9600 Fax: 913-588-9770 | |
Archana Pareek, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, 6040 Delp, Ms 1020, Division Of General And Geriatric Medicine, University, Kansas City, KS 66160 Phone: 913-588-6005 Fax: 913-588-3877 |